S. Ananth

发表

Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140

G. Air, Y. Babu, S. Bantia, 1998, Antimicrobial Agents and Chemotherapy.

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

J. Montgomery, K. Andries, A. Dehghani, 2001, Antimicrobial Agents and Chemotherapy.

Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.

J. Sandhu, Y. Babu, S. Ananth, 2002, International immunopharmacology.

Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent.

J. Montgomery, J. Sandhu, P. Morris, 2001, International immunopharmacology.

Identification of gmhA, a Yersinia pestis Gene Required for Flea Blockage, by Using a Caenorhabditis elegans Biofilm System

B. J. Hinnebusch, Creg Darby, S. Ananth, 2005, Infection and Immunity.

Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.

S. Bantia, S. Ananth, C. Parker, 2003, International immunopharmacology.

Synthesis of a potent transition-state inhibitor of 5'-deoxy-5'-methylthioadenosine phosphorylase.

V. Kamath, P. Morris, S. Bantia, 2004, Journal of medicinal chemistry.

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.

A J Elliott, A Dehghani, J. Montgomery, 2000, Journal of medicinal chemistry.

Oseltamivir and Zanamivir Activity of RWJ-270201 with Those of Comparison of the Anti-Influenza Virus

J. Montgomery, K. Andries, A. Dehghani, 2001 .